 |
|
|
|
 |
|
|
Genmab
| Genmab A/S |
|
|
Public (OMX: GEN) |
| Founded |
1999 |
| Headquarters |
Copenhagen, Denmark |
| Key people |
Lisa Drakeman (President and CEO)
Michael Widmer (Chairman of the board) |
| Industry |
Biotechnology |
| Products |
Pharmaceuticals, antibodies |
| Revenue |
DKK 135.5 million (2006)[1] |
| Profit |
DKK 438.2 million (2006)[1] |
| Employees |
237 (2006)[1] |
| Website |
www.genmab.com |
Genmab A/S (OMX: GEN) is a Danish pharmaceutical company, founded in February 1999 and based in Copenhagen. Internationally, it operates through the subsidiaries Genmab BV in Utrecht, The Netherlands, Genmab Ltd in Hertfordshire, United Kingdom and Genmab, Inc in Princeton, New Jersey, USA, and is publicly traded on the OMX Nordic Exchange and the OMX Copenhagen 20.[2]
Research Pipeline
Status of major offerings in Genmab's research pipeline, as of late 2007.[3]
| Name |
Indications |
Status |
Collaborations |
HuMax-CD4
(zanolimumab) |
Cutaneous T Cell lymphoma (CTCL) |
Phase III |
|
| Non-cutaneous T Cell lymphoma (NCTCL) |
Phase II (completed) |
|
HuMax-CD20
(ofatumumab) |
Chronic lymphocytic leukemia (CLL) |
Phase III |
GSK |
| Non-Hodgkin’s lymphoma (NHL) |
Phase III |
| Rheumatoid Arthritis (RA) |
Phase III |
| Diffuse large B cell lymphoma (DLBCL) |
Phase II |
HuMax-EGFr
(zalutumumab) |
Head and neck cancer |
Phase III |
n/a |
| Non small cell lung cancer |
Phase II |
n/a |
HuMax-IL15
(AMG 714) |
Rheumatoid Arthritis (RA) |
Phase II (completed) |
Amgen |
| Psoriasis |
Phase I |
| HuMax-IL8 |
Palmoplantar pustulosis |
Phase I/II (completed) |
|
| HuMax-CD38 |
Multiple myeloma |
Phase I/II |
|
| R1507 |
Cancer |
Phase I (completed) |
Roche |
| Roche 2 |
undisclosed |
Phase I |
Roche |
| Roche 3 |
undisclosed |
Phase I |
Roche |
| Roche 4 |
Asthma |
Phase I |
Roche |
| HuMax-HepC |
Hepatitis C |
pre-clinical |
Connex GmbH and INSERM |
| HuMax-TAC |
Organ transplant rejection |
Pre-clinical |
|
References
- ^ a b c Annual Report 2006. Genmab A/S (29 March, 2007). Retrieved on 2007-12-19.
- ^ Company Profile from the Genmab website
- ^ http://www.genmab.com/ScienceAndResearch/ProductsinDevelopment.aspx
|
OMX Copenhagen 20 companies of Denmark |
A.P. Møller-Mærsk · Carlsberg · D/S Norden · Danisco · Danske Bank · DSV · FLSmidth & Co. · GN Store Nord · Genmab · Lundbeck · NKT Holding · Nordea · Novo Nordisk · Novozymes · Sydbank · Topdanmark · TrygVesta · Vestas Wind Systems · William Demant
|
|
| |
|
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Genmab". A list of authors is available in Wikipedia.
|
Additional information matching your search term
Additional information was found matching your search for Genmab.
|
|
|
|
|
Top